It is currently Sun Dec 21, 2014 1:00 pm

News News of Drug Pipeline

Site map of Drug Pipeline » Forum : Drug Pipeline

A board to discuss future MS therapies in early stage (Phase I or II) trials.


Antisense Therapeutics

Antisense Therapeutics were trialling an oral drug which targeted the same protein as Tysabri. The company stopped the trial following the Tysabri fiasco. The company has applied to restart the trial (may need to add to Dignan's list of approval given).


http://www.antisense.com.au/dl/415.pdf
Read more : Antisense Therapeutics | Views : 1332 | Replies : 0


Updated Interim NeuroVax(TM) Data

New NeuroVax Data from the European MS Meeting


http://biz.yahoo.com/bw/051003/35350.html?.v=1



Dunmann.
Read more : Updated Interim NeuroVax(TM) Data | Views : 1410 | Replies : 0




FTY720

http://c.moreover.com/click/here.pl?j399628250&w=464753


And another article which also refers to Mylinax (sp?). Still looking at 2008 or 2009 before an oral therapy is available.

http://c.moreover.com/click/here.pl?j399635862&w=464753
Read more : FTY720 | Views : 1619 | Replies : 1


Padma28

I have no idea what Padma28 is but it seems to have some benefit for chronic progressive ms sufferers.


http://www.ever.ch/padma28ms.htm


PS I found some more information - it's a Tibetan medicine.

<shortened url>

It seems to consist of a vast range of ingredients - as our nutrition expert Melody might translate for us.
Read more : Padma28 | Views : 3511 | Replies : 2


Tauferon results

Read more : Tauferon results | Views : 1539 | Replies : 0


GEMSEP1 for SP

Read more : GEMSEP1 for SP | Views : 1300 | Replies : 0


Tovaxin results

Read more : Tovaxin results | Views : 2052 | Replies : 4


Dacluzimab results

Read more : Dacluzimab results | Views : 1370 | Replies : 0


 

Login  •  Register


Statistics

Total posts 222321 • Total topics 23090 • Total members 14618


Contact us | Terms of Service